机构名称：
¥ 1.0
Diabetes Canada 2021 Clinical Practice Guidelines: In 2021, the Diabetes Canada Clinical Practice Guidelines review committee updated its recommendations for glucose monitoring, stating that real-time CGM (rtCGM), like the Dexcom G6, should be used by individuals with type 1 diabetes treated with basal-bolus insulin injections or an insulin pump in order to reduce A1C and increase time in range （TIR），减少低血糖症的持续时间和发病率，在成年人中，改善了生活质量。该指南还指出，使用基底核糖而非目标的2型糖尿病的成年人可能会使用RTCGM减少A1C和低血糖症的持续时间。
RTCGM在加拿大的公共报道*RTCGM在加拿大的公共报道*
主要关键词
相关文件推荐
